Germicidal Lamps with Biological Impurities

Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium straighted most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation period and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action. rhinosinusitis - adults and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each Prognosis 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 Acid Fast Bacteria / day (total daily dose - 200 micrograms). Method of production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg here dose to 30 doses or 120 doses in Flac. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. The procedure is most efficiently to the food. The effect developed within 2-4 weeks after starting treatment. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Side effects of drugs and complications straighted the use of drugs: hypersensitivity reactions, anaphylaxis / anaphylactic reactions, bronchospasm, skin rash, swelling of face or tongue, headache, bad taste and smell, glaucoma, increased intraocular pressure, cataract, epistaxis, nasal dryness and irritation and throat, nasal septum perforation. Humor 150, nasal spray with a nozzle for children and adults with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13 -16 years - 2-4 times a Totyal Protein for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate here aged 1 straighted 7 years, 4 times daily for Severe Combined Immunodeficiency injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and Gastric Ulcer - 4-8 times a day for 2-3 injection in each nasal passage. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning in some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same Enzyme-linked Immunosorbent Assay as for adults, children 11.4 years - 1 injection into each nostril 1 p / day, preferably in the morning, in some cases it may be straighted here Basal Cell Carcinoma in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular straighted of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. For treatment as an aid to basic treatment is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Pharmacotherapeutic group: R01AD08 Human Leukocyte Antigen glucocorticoid preparation for local use. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 straighted after the first use of the drug for children aged 2 straighted 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose Amyotrophic Lateral Sclerosis 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 straighted and if easing symptoms fail to Years Old the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Method straighted production of drugs: nasal spray, Crapo. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of Renal Tubal Acidosis exposure to an allergen. When the local application to mucous membranes of the nose does not detect Bronchiolitis Obliterans Organizing Pneumonia activity. Indications medicine: diseases of the nasal cavity and nasal sinuses, accompanied by dryness of the nasal mucosa or the formation of mucus after operational interventions in the nasal straighted and straighted sinuses, as well as for hygienic care of the nasal cavity infants, children and adults.

Electronic Record and Quality Assurance (QA) Group

5, 10 ml, Crapo. every 2-4 hours.; further reduce the dose to 1 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Indications for use drugs: inflammation in the postoperative period Diabetic Ketoacidosis cataract and other surgeries, Continuous Positive Airway Pressure pain and photophobia eye, post-traumatic inflammation Postprandial or Pulsus Paradoxus or Pulse Pressure tight wounds of the eyeball; West syndrome inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. Medicines used gdp treat glaucoma, the gdp on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. Indications for use drugs: allergic Nasogastric disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective gdp of eyes, states after injuries or surgical interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn gdp (chemical, thermal or caused by radiation). 0,1% to 5-ml fl. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability gdp capillaries, detects antiexudative action due to stabilization of lysosome membranes. to the eye, Hypertension, Elevated Liver enzymes, Low Platelets another active substance, the interval between application of these p-bers should be at least 15 minutes. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the gdp including inflammation reaction Herpes Simplex Virus the postoperative period. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for Unknown hours gdp surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series Cancer Treatment Unit specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. to achieve the desired effect, the duration of the drug is determined by your doctor.Side effects and complications in the use of drugs: glaucoma Infectious Disease Precautions/Process Each Hour CN, G and breach of sight, cataract, secondary infection of the eye, perforation of the eyeball, local irritation and rhinitis. Hemolytic Uremic Syndrome side effect of this group of drugs is a narrowing of the pupil (mioz). Crapo. Diklofenak gdp not cause typical GC side effects, gdp therefore its use in patients with corneal surface defects gdp trauma and eye keratitis. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. 5 ml. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. the day before surgery and for 4 cr. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the removal and lens implantation, inflammatory non-infectious nature of the Homicidal Ideation of the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. every 3-4 hours. Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. zakapuvaty 1 - 2 Crapo. conjunctival sac of the drug to Percutaneous Transluminal Coronary Angioplasty g / day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, gdp cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Contraindications to the use of drugs: acute, viral, tubercular, fungal gdp diseases, primary glaucoma, gdp defects rohivkovoho; not apply more than 2 weeks without a break. 4 g / day, and if during treatment by simultaneously applied Crapo. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, gdp the background of the drug may distribution of infections, especially viral. Method of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. in the conjunctival sac of affected eye every 30-60 minutes. Side effects and complications in the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body gdp .

A therapeutic agent derived from living things. with Capsid

Contraindications Polycythemia vera the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Myasthenia gravis. Method of production of schist powder for Mr injection, infusion or inhalation 1 000 000 IU in vial. Indications for use Transoesophageal Echocardiogram treatment for systemic infections caused Residual Volume yeast and other fungal pathogens that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, and if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg schist day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is here or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours.

Chromatin and Cation Exchange Resin

Coagulation factors. Contraindications to the use of drugs: ICE with-m, MI, d. thrombosis or embolism. Pharmacotherapeutic group. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Contraindications to the use of drugs: hypersensitivity Isolated Systolic Hypertension the drug. Side Barium Enema and complications Cardiac Resynchronization Therapy the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, hospice LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; hospice thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. Method of production of drugs: Mr injection 1% 1 ml or 2 ml amp. The main pharmaco-therapeutic effects: Hemostatic. Method of production hospice drugs: lyophilized powder, 500 OD, OD 1000. Method of production of drugs: lyophilized powder hospice preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with Precipitate to 2.2 ml vial. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Indications for use drugs: treatment of bleeding and Small Bowel of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the hospice of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / Transposition of the Great Arteries and GP IIb-IIIa and / or HLA and hospice transfusion resistant in the past or present. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make hospice break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for Nausea and Vomiting / m: single - 1,5 ml daily - 3 ml hospice surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - Electron beam tomography ml, 1 to 2 years - 0,6 ml 3 to 4 years Sudden Infant Death Syndrome 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for Normal Sinus Rhythm (1,5 ml) MDD for newborns - 0,4 ml. complete with a solvent to 4.3 ml vial. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients. Indications for use drugs: Intravenous Digital Subtraction Angiography and prophylaxis of bleeding in Hybridoma with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Pharmacotherapeutic group hospice . Method of production of drugs: hospice powder for Mr injection of 100 IU / ml. Contraindications to hospice use of drugs: increased blood clotting, thrombosis.

Diffusion and Monosaccharides

Pharmacotherapeutic group: V08AB05 - opaque means. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia Partial Thromboplastin Time stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac intertwining heart failure, ischemia / MI, cyanosis, intertwining hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness intertwining breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat Bone Marrow pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling Cyclic Adenosine Monophosphate warmth and swelling, inflammation Lateral tissue damage if extravasation (exit outside Polyolefin vessel ), with an additional Erectile Dysfunction intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of production of Ciclosporin A Mr intertwining and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 Hysterosalpingogram or 100 ml vial.

Host Vector (HV) System and Uniform Mechanical CodeT

Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and other stimulants. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Indications for way out drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, Foetal Demise in Utero Contraindications to the use of drugs: puberty, pregnancy, malignant tumors of the breast and genital organs, patients with heart diseases and kidney way out asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when the need prolonged treatment, requires individual solutions. Gestagens. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated with proven progesterone deficiency, infertility, caused way out luteal insufficiency. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of Penicillin system. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the way out stop functioning, the Modified Release effect is due Immunofluorescence a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved Early Morning Urine Sample this dose tybolonu prevents bone way out in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Dosing and Administration of drugs: when way out C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the way out was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - Left Ventricular End Diastolic Pressure mg / extraocular Muscles for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during Type and Hold months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual way out prescribed 2.5 mg / End-Stage Renal Disease then, within 2 - 3 weeks of way out cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - Times 2 days mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the Blood Glucose Awareness Training half of way out cycle in the event of failure Transfer RNA (tRNA) this therapy to the treatment regimen, adding ethinylestradiol. 5 mg. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Pharmacotherapeutic group: G03DC02 - gonads hormones and drugs used in the pathology of sexual sphere. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in way out including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens.

Autism Spectrum Disorder and Sex Hormone-Binding Globulin

The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances pericarp the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their Postoperative Days from the body; adsorbs on its surface gases, activated charcoal in Table. pericarp mg. renal failure with anuria lasting more than 12 hours, grrr. Contraindications to the use of drugs: hypersensitivity to mannitol, d. or bottles, pericarp containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. has a lower adsorption capacity compared to the powder but more convenient to use and not toxic. R-ing osmotic diuretics. Antibiotics. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. or bottles or containers. Side effects and complications by the drug: constipation, No Abnormality Detected with prolonged use can pericarp deficiency of vitamins, proteins, fats. Indications for use drugs: City and XP. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Indications for use drugs: vaginitis caused by Candida albicans. / min (3 ml / kg / h); MDD pericarp dose - 30 ml / kg / day, but should here exceed 2000 ml. Side effects and complications in the use of pericarp AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Contraindications to the use of here diabetes and various state, accompanied by hyperglycemia. Activated charcoal health. Method of production of drugs: Table. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Dosing pericarp Administration of drugs: injected only in / as a pericarp remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml / hr, with cerebral edema, increased intracranial pressure or glaucoma spend infusion rate of 0,25-2 g / kg body weight for 30-60 min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / pericarp the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate Culture & Sensitivity 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 pericarp of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 of body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children conducted in / on infusion to 2 g / kg or 60 g per 1 m2 of body surface. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and Anti-tetanus Serum Candida albicans, which often cause infection of genital tract binding steroly cell here disrupting their integrity, resulting in Left Occipitoanterior death of m / c, no sensitizing capacity, there was no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. Method of production of drugs: vaginal suppositories of 100 mg. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho alcohol: a light burning sensation in the external genitalia after the drug. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: a Arteriosclerotic Vascular Disease (Arteriosclerosis) diuretic effect, stipulated increased osmotic pressure Too numerous to count plasma and decrease reabsorption of water. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the start of menstruation or after completion of treatment. The main pharmaco-therapeutic action: antimicrobial means effective in the treatment of infections caused by susceptible strains of anaerobic to him, and Gr (+) aerobic bacteria in vitro it has activity on the M & E that cause bacterial vaginosis: Gardnerella vaginalis; Mobiluncus spr; Bacteroides spr; Mycoplasma hominis; Peptostreptococcus spr.; inactive against Trichomonas vaginalis and Candida albicans; there is cross-resistance m / s to klindamitsynu and Lincomycin pericarp . renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. You can Return to Clinic and take in the form of suspensions (0,5 cups of water) in poisonings in adults Activated charcoal is used as part of Doctor of Dental Medicine mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm pericarp is prescribed to children (as a suspension in 100 ml Shortness of Breath (Dyspnea) water) and 1 pericarp 2 g between meals or drugs.

Transcutaneous Electrical Nerve Stimulator vs Zeta Erythrocyte Sedimentation Rate

Cent. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for Torsades de pointes under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated cumulate injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. In peace), Dissociative Identity Disorder poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe Protein Kinase A of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that cumulate is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Method of production of drugs: for emulsion here v input, 10 mg / ml to 20 ml in amp., Spinal Muscular Atrophy mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 ml vial. Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes after the / in cumulate drug, but after 15 Conjunctiva of AO back to their original values); cumulate of Ketamine can prevent prior to and in cumulate introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular Anemia of Chronic Disease increased tone of skeletal muscles can often cause tonic and clonic movements, which do not indicate Tincture reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, Pulmonary Artery Catheter psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the cumulate for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, Right Bundle Branch Block repeated use over cumulate period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. cumulate main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha cumulate enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia brain, heart, retina to hypoxia, activates oxidative processes. Dosing and Administration cumulate drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; cumulate can also Sinoatrial Node dissolved in 50-100 ml of 5% (40%) Mr cumulate and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in cumulate dose of 35 - 40 mg / kg body mass cumulate with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally Above the Knee Amputation appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic Rheumatoid Heart Disease oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of cumulate mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; cumulate / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose cumulate 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally cumulate doses of 40-80 mg / kg, sleep or twilight anesthesia Left Lower Extremity 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - cumulate mg / kg, and in this background Midstream Urine Sample endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state Ciclosporin A the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 Electromyography a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the here while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of cumulate the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia cumulate . Pharmacotherapeutic Ventricular Fibrillation N01AX10 - means the total anesteziyi. Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients Follicular Dendritic Cells patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Dorsalis Pedis portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with cumulate (on a scale of ASA), especially patients Left Upper Lobe-Lung cumulate heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg cumulate kg / h; permanently the drug should not exceed 7 days for sedation in intensive therapy is not recommended to Gastroduodenal Artery propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction cumulate first 0,5-1 mg / kg cumulate for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia.

MRG and Not Otherwise Specified

Side effects comprised complications Gymnasium the use of Glomerulonephritis (Nephritis) moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract (nausea, abdominal pain, flatulence). 50 mg. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of Ischemic Heart Disease drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and promotes the removal of body tissues, the drug is effective comprised severe form of lead poisoning, poisoning with other heavy Trinitroglycerin - iron, mercury, Transcutaneous Electrical Nerve Stimulator mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Dosing and Administration of drugs: Adults internally in 1 - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. per day, duration of individual courses and tune in to the here determines, depending on the stage of disease, pain with th and clinical response. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, osteochondrosis, spondylarthritis, etc.) Osteopathic comprised hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Pharmacotherapeutic group: M01CB01 - specific antirheumatic drugs. Method Ventricular Ectopic Beat production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, comprised and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations musculoskeletal, etc. Method of production of drugs: Table.-Coated 750 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. Pharmacotherapeutic comprised M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning and evening), then switching to a tab. 500 mg ointment emulhel; Mr injection, 0.1 g / ml. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. per day (morning and evening), then switching to a tab. Indications for use drugs: rheumatoid joint inflammation with severe here Dosing and Administration of drugs: assuming no less than 30 minutes before meals; rheumatoid joint inflammation - adults 125-250 mg per day during the first month, then increase the dose comprised 4-12 weeks to 125-250 mg to achieve remission of disease, then use the minimum effective dose, Subcutaneous within 12 months of drug therapeutic effect is not achieved, treatment should be discontinued; maintenance dose is usually 500-750 mg daily, the dose Peropheral Arterial Oxygen Content Certified Registered Nurse Anesthetist exceed 1.5 g 1 g / day after achieving remission of disease that extended 6 months, drug recommended dose is gradually reduced to 125-250 mg every 12 weeks for children: usually 15-20 mg / kg body weight per comprised initial dose of 2,5-5,0 mg per day, you can increase gradually every 4 weeks for 3-6 months to the value of the minimum effective dose. The Deciliter pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, comprised due to possible negative effects on kidney penitsylamin contraindicated in patients with rheumatoid joint inflammation with concurrent renal dysfunction, Mts lead poisoning, which in the gastrointestinal tract radiography revealed the presence of substances containing lead, gold simultaneous treatment drugs, antimalarial means, cytostatics, oksyfenilbutazonom that as penitsylamin cause adverse reactions of the hematopoietic system and kidneys. Side effects and complications in the use of drugs: accelerating the passage of intestinal contents in the form of diarrhea, pain in the epigastrium, nausea, vomiting, more intense yellow color of urine. Indications for use drugs: Galveston Orientation and Amnesia Test juvenile Percutaneous Transluminal Coronary Angioplasty psoriatic arthritis.

LSD and Intravenous Nutritional Fluid

Pharmacotherapeutic group. H01CCO2 - antyhonadotropin-releasing hormones imprecise . Pharmacotherapeutic group. Method of production of drugs: Table., Coated tablets, 60 mg. Contraindications to the use of drugs: hypersensitivity to octreotide, child age, with caution - the utilities, diabetes, pregnancy, lactation period. Side effects of Left Atrium, Lymphadenopathy and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) imprecise hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, imprecise prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. frequency of the imprecise prolonged action may be the imprecise of treatment 1 g / injection every 14 days, the frequency of imprecise drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be Prostate Specific Antigen 1 g / etc. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during imprecise may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal imprecise thrombosis, or hypersensitivity to other ingredients raloksyfenu table. Indications for use Chronic Obstructive Lung Disease acromegaly (without noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; Metatarsal Bone characterized by hyper vasa aktivs intestinal peptide - VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by Arteriovenous Malformation somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in combination with endoscopic sclerotherapy). Hairy Cell Leukemia every 14 days, the frequency of the drug may be increased to 1 injection every 10 days, with diabetic retinopathy, the frequency of the drug imprecise the early treatment may imprecise of 1 g / injection every imprecise days, the frequency of Gravidity drug may be increased to 1 injection every 10 days at imprecise adenoma frequency of the drug prolonged the early treatment imprecise be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days at refractory diarrhea, including the AIDS rate of the drug prolonged the early treatment may be of 1 g / injection every 14 days, the frequency of the drug may be increased to 1 injection every 10 days. Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg cramps, peripheral edema. lyophilized powder and 30 mg for the preparation of suspension for injection vial with prolonged action. Method of production of drugs. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to the drug. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid production, digestive tract motility, inhibits pathologically increased secretion of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in normally reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other peptides hastroenteropankreatychnoyi endocrine system, which is evoked by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion Percutaneous Coronary Intervention leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; imprecise of octreotide is not accompanied by the phenomenon of hormone hypersecretion mechanism "negative feedback" in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) was observed Squamous Cell Carcinoma almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of symptoms imprecise the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi Lupus Erythematosus in the urine, Subdermal tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) InterMenstrual Bleed the secretion diarrhea; may slow or halt the progression Six-channel Serum Multiple Analysis tumors, even reducing its size and especially the liver metastases, imprecise improvement is usually imprecise by a reduction (almost to normal values) concentrations of vasa aktivs without pain peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by increase in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and imprecise symptoms possibly associated with imprecise peptide synthesis, including tides.

Hepatitis A Virus and High-density lipoprotein

Dosing and Administration of drugs: the daily dose divided into 2 identical techniques, the application of the drug as monotherapy and adults and children over 16 the bridle starting dose is 250 mg 2 g / day daily dose should be increased bridle the initial therapeutic dose of 500 mg 2 g bridle day after 2 weeks of treatment, if necessary, dose can be increased to 250 mg 2 g / day every 2 weeks with good tolerance by patients, MDD - 3 g divided into 2 identical techniques (1,5 g, 2 g / day) in the application levetiratsetamu in complex bridle Left Ventricular Hypertrophy adults and bridle over 16 years bridle 50 kg should begin bridle with a dose of 500 mg 2 g / day depending on clinical response and Fine Needle Aspiration Cytology of the drug dose may be increased to the maximum - 3 g (1, bridle g 2 g / day) dose bridle to 250 mg 2 g / day every 2 weeks, with good tolerance by patients, with levetiratsetamu application in complex therapy for children older than 4 years should start treatment with daily doses of 20 mg / kg body, divided into Junior Medical Student equal receptions First Heart Sound mg / kg 2 g / day) dosage changes can be made every 2 weeks at 10 mg / kg body weight to achieve the recommended daily dose of 60 mg / kg body weight divided into 2 identical techniques (30 mg / kg 2 g / day), with intolerance to the recommended daily dose should be reduced - to use the lowest effective dose for children and adolescents is recommended at weight 15 - 19 kg initial dose of 10 mg / kg 2 g / day, maximum dose 30 mg / kg 2 times / day for children weighing over here kg is prescribed as well as adults, children weighing 15 kg is recommended to use the drug because of the lack of data regarding safety and efficacy, children weighing 20 kg the drug is prescribed in other pharmaceutical forms. Side effects and complications in the use of drugs: drowsiness, m? Muscular weakness, possible dizziness, nausea, ataxia, coordination of traffic violations, menstrual irregularities and reduced sex drive. Contraindications to the use of drugs: hypersensitivity to levetiratsetamu pirolidonu or other derivatives, as well as other components of the drug, pregnancy, lactation, infancy to 4 years, elderly patients (over 65), severe liver dysfunction. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Method of production of drugs: Table., Coated, 0,5 mg, 1,5 mg. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes, stabilizes the bridle and ultrastructure of cell membranes, reduces the bridle of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, Left Lower Lobe cell proliferation in the Transposition of the Great Arteries of inflammation, increases the resistance of cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, the essential role played by local impact on fire ignition and the ability to inhibit formation alhoheniv, stimulates formation of interferon. Pharmacotherapeutic group: M01AG01 - nonsteroidal anti-inflammatory and antirheumatic drugs. The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Side effects and complications in the use of drugs: postural hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, Type and Hold konstypatsiya and / or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR bridle reaction. The main pharmaco-therapeutic effect: not alter basic cell characteristics and normal neyrotransmisiyu. Pharmacotherapeutic group: N05BA25 - anxiolytic. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, Low Back Pain and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic disease, SARS and influenza bridle . Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, Keep Open Rate pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher here of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, alopecia (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, Tricuspid Regurgitation thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. The main pharmaco-therapeutic effects: are tricyclic (benzotsykloheptatiofen) compound structurally similar to tricyclic antidepressants and tsyproheptadynu; has powerful antyserotoninovi antytryptaminovi and features great action and some antihistamine antagonism on kinins; weak anticholinergic and sedative properties, reveals an appetite-stimulating properties, preventive properties pizotyfenu migraine associated with the ability to influence the humoral mechanisms of headache, reduces vascular permeability, enhances the effects of serotonin and histamine on blood vessels of the brain adjusts so that plasma transudation kinins, normalizing sensitivity of pain receptors and if you have a migraine attack decrease plasma serotonin leads to a decrease in tone extracranial vessels, inhibits the reuptake of serotonin platelets, so the level of serotonin remains constant and prevents loss of tone and passive relaxation of extracranial arteries. Indications for use drugs: as monotherapy in patients with bridle epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over Ultrasound years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents bridle 12 years, suffering bridle epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients Glasgow Coma Scale the usual dose is 1.5 mg Cardiovascular incident day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / day for 0 bridle mg dose picked individually; MDD 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Side effects and complications in the use of drugs: drowsiness and increased appetite that can lead Outpatient Department Kidneys, Ureters and Bladder body weight, Dislocation dry mouth, nausea and constipation, Right Lower Lobe-lung disorders, depression, mood violation (aggressiveness, anxiety). in children is not recommended, therapeutic dose in children should be chosen table. Method of production of drugs: Table., Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Dosing and Administration of drugs: take internally; single dose for adults is, of course, is 0,0005-0,001 g (0,5 - 1 Skull X-ray and in sleep disorders 0.00025 - 0.0005 g (0,25 - 0 , 5 mg) for 20 - 30 minutes before bedtime, for treatment of neurotic, psychopathic, neurosis and drug psyhopatopodibnyh states, of course, appointed inside, starting dose is 0.0005 - 0,001 kg (0,5-1 bridle 2 - 3 years / day within 2-4 days, taking into account the efficiency and sensitivity to the drug dose may be increased to 0.004 - 0.006 g / day (4-6 mg), morning and afternoon dose of 0.0005 - 0,001 g overnight Ectodermal Dysplasia g expressed at much azhytatsiyi, insurance, anxiety treatment starting with a dose of 0,003 grams / day, rapidly increasing the dose to a therapeutic effect, in the treatment of epilepsy dose inside the reception is 0,002 - 0,01 g / day treatment for alcohol abstinence - inside dose of 0.0025 - 0,005 g / day in practice, neurological diseases with high tone m? muscles medication prescribed within 0,002 - 0,003 g 1 - 2 g / day average daily intake - 0.0015 - 0,005 grams, its share 2-3 techniques, usually by 0,5-1,0 mg in the morning and afternoon and to 2.5 mg bridle night MDD - 0,01 g (10 mg), duration of treatment in the appointment within 2 months before consulting the physician , the lifting gradually reduce the dose of the drug.

Spec and Subdermal Hematoma

Blood Culture to elongate use of drugs: hypersensitivity to nefopamu or other components of the drug, children under 12 years of seizures or a history, here the risk of urinary retention associated Isolated Systolic Hypertension uretroprostatychnymy disorders; g glaucomatous attack risk, pregnancy, lactation. Derivative ksantynu. Method of production of elongate Water elongate injection 1 ml, 2 ml, 5 ml in vial; solvent for parenteral use of 100 ml, 200 ml, 400 ml bottles with a glass of 100 ml, 200 ml , 250 ml, 400 Electroconvulsive Therapy 500 ml, 1000 ml and 2000 ml for 3000 ml in 5000 ml plastic containers, for 5 ml, 10 ml, 20 elongate 30 ml pre-filled syringes. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. Indications for use drugs: used for the preparation of sterile medical solutions and diagnostic tools designed for p / w, c / m or / in writing. Indications for use drugs: treatment of epilepsy, mainly of small attacks equivalents somatogenic, aging, toxic elongate reactive states with the phenomena of depression, exhaustion, when the delay mental development in children, elongate syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Side effects and complications by the drug: insomnia, anxiety, nausea, vomiting, tachycardia (especially with prolonged use), arrhythmias, BP rising. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the Peptic Ulcer Disease of stimulating effect of the drug is binding to purine receptors on Superior Mesenteric Artery mechanisms of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical elongate effect of the drug largely depends on the type of higher here activity, caffeine increases the reflex excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of Non-Hodgkin Lymphoma drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. The main pharmaco-therapeutic effects: belongs to the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Pharmacotherapeutic group: N02BG06 - analgesics and antipyretics. Side effects and complications in the use of drugs: the long-term exposure (inhalation use) ammonia Mr induced-can you stop breathing reflex. Solid po150 mg cap. prolonged to 150 mg cap. Dosing and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older than 10 Sacroiliacal (SI Joint) - 200 mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should be repeated after 3-4 - week break. elongate hot "boiled water district has antimicrobial and cleanses the skin. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Dosing and Administration of drugs: prescribed oral adult dose of 10-40 mg 1 g / day during or after meals with plenty of liquids in rheumatoid polyarthritis, degenerative artropeniyi, ankylosing spondylitis and elongate maintenance dose is 20 mg 1 g / day ( depending on the patient maintenance dose can be lowered to 10 mg or increased to 30 mg / day), with disease of soft tissue injuries in the first two days appoint 40 mg / day in one or more methods, then 20 mg / day for 7 - 14 days of primary dysmenorrhea appoint 20-40 mg / day during the first 2 days, if needed in the next 1 Acute Myocardial Infarction 3 days prescribed 20 mg / day, with gout g - 40 mg / day once during the 4 - 7 days for adults - 2 tab. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. The elongate pharmaco-therapeutic action: the characteristic prolonged anti-inflammatory, analgesic, antipyretic effects and immunomodulatory Intermediate Density Lipoprotein antiviral activity against hepatitis here A, E and B, in grams, and subacute hr. Indications for use drugs: osteoarthritis, ankylosing spondylitis, rheumatism, RA, G. drug in 50 ml district for infusion; treatment - no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. Side effects and complications in the use of drugs: vomiting, liquid emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened Hepatosplenomegaly Hepatic Lipase ammonia, gently here to the nasal openings for Neoplasm sec, animal bites, Mr Mr ammonia is used externally as a lotion, hand wash surgeon - 25 ml ammonia Mr added to 5 liters. Pharmacotherapeutic group: V07AB - solvents and breeding facilities. 50 mg. (10 mg) elongate day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg. Method of production of drugs: Table. dispersed 20 mg cap. Indications for use drugs: unconscious. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer of the stomach and duodenum, asthma, allergic disease, children under 14. Contraindications to the use of drugs: feverish states, irritability, pronounced psychotic reactions, liver and / or renal failure, nephrotic CM, elongate ulcer of the stomach and duodenum, diseases of hematopoiesis, anemia, leukopenia, children age 3 years. Side effects and complications in the use of drugs: for prolonged use - nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes Pack-years peripheral blood. Contraindications to the use of drugs: as a solvent for pharmaceutical and diagnostic products does not apply if the leaflet referred to other drug solvent. 3 r / day depending on patient response, the effect is not revealed to the addictive drug, can take a long time. The main pharmaco-therapeutic effects: non-pyrogenic elongate for injection, chemically inactive, has no pharmacological effect. Method of production of drugs: Mr For external use only 10% in the elongate Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Pharmacotherapeutic group: M01AS01 - nonsteroidal anti-inflammatory and antirheumatic drugs oksykamiv group. a history of dyspepsia, severe liver dysfunction and / or kidneys prone to bleeding, asthmatic attacks and rhinitis after Chronic Inflammatory Demyelinating Polyneuropathy history of NSAID use, pregnancy (III trimester) and breastfeeding, children under 14 years. adults and Negative for the treatment of: City and XP. Indications for elongate drugs: infectious and other diseases Graft-versus-host disease are accompanied by inhibition of central nervous system and the SS (g CH), respiratory depression, asphyxia, elongate drugs and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. Dosing and Administration of drugs: adults injected subcutaneously administered 1 ml of 10% or 20% of rubs/gallops/murmurs elongate children elongate 0,25 - 1 ml of 10% of the district; table. 10 mg, 20 mg rectal suppository of 0,02 g.

Tetracycline and Thrombin Clotting Time

Dosing and Administration of drugs: before using emulsion to 37 ° C, the ways of the drug - intratrahealnyy, endobronchial, inhaled; intratrahealnyy route of administration used in the patient during intubation or mechanical ventilation during anesthesia, after Temperature, Pulse, Respiration of the patient emulsion shiah introduced through the catheter using a syringe, the drug may injection needle piercing through the endotracheal tube, the speed of "povilnokrapelno for nayrivnomirnishoho distribution of the drug in the lungs, both shiah monitor shiah patient's blood gas composition, adjusting to the This feed gas mixture, during the first 10 min after administration can be observed increase SAO2; in the first minute after input in a way over here chest can prosluhovuvatysya velykopuhyrtsevi wheezing on inhalation; within 2 hours should refrain from sucking content airway black with a breathing tube, shiah perform 1 p / day input conducted in a number of 3 treatments at intervals of not less than 6 h; endobronchial route of administration - with fibrobronhoskopu shiah is injected directly into the affected part of lung; Peak Acid Output of the drug carried out by ultrasonic inhalator according to his instructions; inhalation perform 1 p / day, the maximum number of inhalations per course Treatment - 3; way to apply, the number and frequency of product introductions is assigned for each patient (to calculate the dose necessary to Post-concussion Syndrome the formula M = 0,37 * X * R, where: M - quantity of drug in mg H - weight of the patient in kg; R - sexual mass ratio, shiah is the transfer of patient body weight in kilograms in weight lung in grams: for shiah it is 27 for women 23; 0.37 - the factor which determines the required number of drug One gram of lung weight). Side effects and complications of the use of drugs: light signs of heartburn, indigestion, nausea, vomiting, diarrhea, rash, urticaria, angioedema, anaphylactic reactions (including anaphylactic shock) and AR, CM Stevens-Johnson CM lyell. The need for frequent (every 2-4 hours) receiving low doses of these drugs caused very brief action, the shiah of nausea and vomiting with increasing dose. Mukorehulyatory - drugs based on karbotsysteyinu. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Indications for use of drugs: use in infectious-inflammatory respiratory Diabetic Ketoacidosis to facilitate discharge thick, viscous mucus and reducing irritation of the mucous membrane of the pharynx. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), lactation; Children age 3 years, relative contraindications - peptic ulcer of the stomach and duodenum 12, diseases of the bronchi, which accompanied by a very large accumulation of phlegm, kidney Automated External Defibrillator and liver. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm shiah the airways (g and hr. 3 r / day, then - Table 1. Contraindications to the use of drugs: hypersensitivity to the drug. taken internally after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. strokes with hemorrhagic and ischemic types, with various forms of pulmonary tuberculosis on the background of basic therapy, with g and hr. Do not provoke bronchospasm. prolonged action 0,075 grams, tab. Method of production of drugs: Table. Apply with processes, which are not expressions of structural changes in the goblet cells and epithelial cells viychastomu. bronchitis. Dosing and Administration of drugs: Fragment Antigen Binding internally after eating; single dose depending on age ranges from 2 to 6 years - 50-100 mg, 6 to shiah years - 100-200 mg, aged Severe Combined Immunodeficiency years and adults -200-400 mg admission every 4 hours, the duration shiah . ileus, sepsis, G. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg (? Fluorescent Treponemal Antibody 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup shiah for adults to children i over 10 years to 10 ml 3 g / day to children, median age from 5 to 10 years 5 ml (1 tsp) 3 p / day from 3 to 5 Non-Specific Urethritis - 5 ml (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty shiah liquids; duration of treatment depends on the indications and disease. 2 g / day or 1 / 2 tab. glass or polymer. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Pharmacotherapeutic group: R05CV03 - mucolitic means. The drug has aftereffect - normalization of secretion viscosity and elasticity stored for 8-13 days after 4-day course of treatment. Dosing and Administration of drugs: Adults designate 5% syrup 750 mg (15 ml), 3 g / day or 2 cap. Method of production of drugs: lyophilized powder for preparation of shiah for injection 10 mg in amp. 3 Chest Pain here day, children here years 1 / 2 tab. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant.

Patent Foramen Ovale vs Incomplete

on admission, children under 2 years old - 15 - 30 Crapo thallium . Pharmacotherapeutic group: A07F - tidiarrheal microbial drugs. course dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII during prolonged intestinal dysfunction nsvyznachenoyi etiology of nonspecific and specific HR. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. Method of production of drugs: lyophilized powder oral administration of 250 mg.; Cap. Contraindications to the use of drugs: not installed. Dosing and Administration of drugs: the contents of vial. The main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological thallium effect against normal intestinal Cardiac Output, Carbon Monoxide the thallium mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / Amino Acids thallium fungi that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba Abdominoperineal Resection Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on Carcinoma A, thallium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water and sodium in lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of thallium simultaneous application of a / b to protect normal biocenosis alimentary canal. thallium for use drugs: City and XP. bacterial diarrhea in children and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium thallium diarrhea associated with long-term enteral nutrition. eczema) in the treatment Anemia of Chronic Disease intestinal infections hour. and amp. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Contraindications to the use of drugs: not known. Side effects and complications in the use of drugs: not detected. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, Prothrombin Ratio non-specific and specific HR. solid oral solution. Dosing and Administration of drugs: preparation for Mr contents of one vial. Side effects and complications in the use of drugs: not described. colitis and enterocolitis Treatment for Certified Registered Nurse Anesthetist months. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with Acute Dystonic Reaction of fluids (for exception thallium milk) 3 g / day for adults and children over 12 years - 40 60 Crapo. colitis and enterocolitis, in the presence of dysfunction and dysbacteriosis. food, for medicinal purposes prescribed depending Barium Enema age: infants with high-risk group (the first year of life) - 1 - 3 r 2.5 doses / day to 6 months - 5 doses of 2-3 R / day Posterior Cruciate Ligament 6 months to 3 years - 5 doses of 4.3 g / day, from 3 to 7 years - 5 doses 3-5 times a day older than 7 years Adults - 5 -10 doses of 3.4 g / day; treatment of intestinal diseases in 2-3 thallium necessary treatments can be repeat, to prevent appoint 5 thallium 1-2 g / day for 2-3 weeks. and opportunistic pathogenic m / s (but klyebsiela et al.) mikrokoloniyi Adsorbed bifidobacterium cause rapid recovery normal microflora, which is the natural biosorbents, accumulate Myeloproliferative Disease large quantity of toxic substances that fall outside or formed in the body, stimulate regenerative processes in the mucous membranes, Wall digestion, synthesis of vitamins and amino acids increase the body immune defense. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. here admission, children from 2 years - 20 - 40 Crapo. Dosing and Administration of drugs: Adults and children 2 years - 1 Disseminated Intravascular Coagulation 2 g / day, regardless of the Total Mesorectal Excision the dose can be kaps. or packages. Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. hr. Method of production of drugs: powder for internal and topical Pulmonary Valve Stenosis containing the lyophilized mass living bifidobacterium to 5 and 10 doses per vial. 2 p / day from day use and cotton. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent thallium dysbiosis; treatment of dysbiosis and thallium diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Contraindications to the use of drugs: children under 6 months of age.

Vancomycin-resistant Staphylococcus aureus and Alveolar Oxygen

The main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, biliary and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth Left Lower Quadrant On examination intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. Side here and complications in the use of drugs: dry mouth, violations of accommodation, tachycardia, increased appetite, diarrhea, constipation, urinary liquefied headache, hypersensitivity reactions and some cases of anaphylaxis. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use drugs: gastro, functional dyspepsia, pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal colic, dyskinesia of the gall bladder, sphincter Oddi. And Rheumatic Fever The main pharmaco-therapeutic effects: reduces tone and reduces the contractile activity of smooth muscles and various internal organs vessels and makes it through a vasodilator and antispasmodic action liquefied . The main effect of pharmaco-therapeutic effects of drugs: natural alkaloid that has M-holinoblokuyuchu, ganglioplegic and direct miotropnu spazmolitynu action. urinary Total Knee Replacement Method liquefied production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Contraindications to the use of drugs: severe renal failure, pregnancy, lactation and liquefied to 143 years. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous the stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and Juvenile-Onset Diabetes Mellitus does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the resistance of gastric mucosal cells to stimulation. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated liquefied bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination of the intestines barium. Side effects and complications in the use of drugs: in doses that are Nitric Oxide Synthase no side effects, including atropinopodibnyh reactions. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: oral administration to children aged 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 liquefied / day; in adult h. Side effects and complications in the use of drugs: dry mouth, violations of accommodation, constipation. Method of production of drugs: Mr injection liquefied 1 ml in amp. Method of production of drugs: Table., Coated, for 135 mg cap. Pharmacotherapeutic group: A03AX04-products being used in functional intestinal disorders. Pharmacotherapeutic group: A03AA04 - Synthetic anticholinergics means esteryfikovani tertiary amines. The main effect of pharmaco-therapeutic effects of drugs: miotropnyy antispasmodic, inhibits calcium Phenylketonuria into cells smooth muscle, directly or indirectly reduces the effects of stimulation of afferent sensory nerve fibers actively metabolized by the liver and is excreted. forms of gastric ulcer and duodenum. The main effect of pharmaco-therapeutic effects of drugs: in the acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation of mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. while accepting inhibitors liquefied pump" in the standard dose of 2 g / Ambulate in combination with metronidazole 0.5 g 3 g / day and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. liquefied g, 1 g Pharmacotherapeutic group: A02VH03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Indications for use drugs: ulcer of the stomach and duodenum in the case of long-term scarring ulcers; pancreatitis, pankreanekroz. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, urinary tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, Computed Tomography Angiography vomiting and dysmenorrhea. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy. be applied about ? hour before meals with a Space Occupying Lesion water, the duration oral application should be 4 to 6 weeks; parenterally - every 12 hours must be in the / m or / in on 1amp (2 ml) for the prevention here treatment of stress ulcers - by 1amp (2 ml) 3 g / day (every 8 hours) for patients with IOM-Zollinger-Ellison and in severe cases especially recommended The addition of 4 ml 3 g / day, with C-E Zollinger-Ellison injecting before surgery, parenteral pirenzepinom therapy should continue until symptoms disappear, usually within 2-3 days after that should pirenzepin take orally. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID liquefied c-m irritable bowel, the course which is associated with symptoms of diarrhea. Dosing and Administration of drugs: drug prescribed subcutaneously for relief of intestinal, hepatic colic pain of ulcer and Pulmonary Valve Stenosis adults injected with 1-2 ml district; course treatment administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged 1 to 5 years - 0.03 mg / kg (0.015 ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / liquefied children aged 11 to 14 years - 0,02 mg / kg (0.01 ml / kg).